Iterum Therapeutics plc (ITRMF) Accumulated Expenses (2017 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Accumulated Expenses of $5.2 million for Q3 2025, up 49.37% year-over-year from $3.5 million in Q3 2024, and up 757.89% quarter-over-quarter from $608000.0 in Q2 2025.
Iterum Therapeutics plc (ITRMF) Accumulated Expenses (2017 - 2025) Analysis & Trends
Iterum Therapeutics' Accumulated Expenses history runs 9 years deep, the most recent figure standing at $5.2 million for Q3 2025.
- In Q3 2025, Accumulated Expenses rose 49.37% year-over-year to $5.2 million; the TTM figure through Sep 2025 stood at $5.2 million (up 49.37% YoY), while the FY2024 annual figure was $2.7 million, down 3.32% from the prior year.
- Accumulated Expenses for Q3 2025 stood at $5.2 million, up from $608000.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $9.0 million in Q3 2023, with the low at $523000.0 in Q2 2021.
- The 5-year median for Accumulated Expenses is $2.1 million (2021), against an average of $2.6 million.
- The sharpest annual moves came in 2022 and 2024: Accumulated Expenses soared 463.68% in 2022, then plunged 68.41% in 2024.
- Iterum Therapeutics' Accumulated Expenses stood at $771000.0 in 2021, then jumped by 463.68% to $4.3 million in 2022, then sank by 36.91% to $2.7 million in 2023, then declined by 3.32% to $2.7 million in 2024, then surged by 96.76% to $5.2 million in 2025.
- Business Quant data shows ITRMF's Accumulated Expenses at $5.2 million in Q3 2025, $608000.0 in Q2 2025, and $2.9 million in Q1 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 608,000.00 |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 9.05 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 3.60 Mn |
| Dec 31, 2022 | 4.35 Mn |
| Sep 30, 2022 | 3.73 Mn |
| Jun 30, 2022 | 1.82 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 771,000.00 |
| Sep 30, 2021 | 769,000.00 |
| Jun 30, 2021 | 523,000.00 |
| Mar 31, 2021 | 2.08 Mn |
| Dec 31, 2020 | 966,000.00 |